Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
British Journal of Haematology|March 6, 1998
Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphomaT Miyamoto, H Gondo, Y Miyoshi, et al.Leukemia|February 13, 2004
Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cellsR Suzuki, J Suzumiya, S Nakamura, et al.European Journal of Haematology|December 12, 2001
Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in JapanK Tamura, H Sawada, Y Izumi, et al.Bone Marrow Transplantation|December 17, 2003
Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantationT Mori, S Mori, Y Kanda, et al.Journal of Hematotherapy|February 1, 1996
G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantationM Harada, K Nagafuji, T Fujisaki, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximabR Seki, K Ohshima, T Fujisaki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 24, 1999
[A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group]T Chou, T Ishiguro, K Imajo, et al.Bone Marrow Transplantation|October 24, 2000
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcomeS Shiobara, S Nakao, M Ueda, et al.Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|March 22, 2001
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: indications and dose escalationS Shiobara, S Nakao, M Ueda, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 24, 1999
[An early phase II study of autologous peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission. Japan Blood Cell Transplantation Study Group]F Kawano, T Kiyokawa, K Shinagawa, et al.Pageof 10